The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) asked CRA to evaluate the policies that host governments of middle-income countries use to encourage investment in innovative activities and the implications for future innovation. CRA consultants looked at eight countries and concluded that there are six key lessons that appear to be critical for success. Read more in the article here:
Overcoming the funding challenges of bringing digital health technologies to market
Digital health is a rapidly emerging field showing significant potential to improve the quality and efficiency of healthcare systems around the world, and more...